Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Squarepoint Ops LLC

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

LENZ Therapeutics, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

(CUSIP Number)

04/01/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Squarepoint Ops LLC

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,593,246.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,593,246.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,593,246.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Squarepoint Capital LLP

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,593,246.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,593,246.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,593,246.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Squarepoint Operations Private Limited

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

SINGAPORE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,593,246.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,593,246.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,593,246.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Squarepoint (DIFC) Ltd

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

UNITED ARAB EMIRATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,593,246.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,593,246.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,593,246.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Squarepoint Master Fund Limited

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,590,333.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,590,333.00

Aggregate Amount Beneficially Owned by Each Reporting Person

1,590,333.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP No.

Names of Reporting Persons

Squarepoint Core Master Fund Limited

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

Sec Use Only

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,913.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,913.00

Aggregate Amount Beneficially Owned by Each Reporting Person

2,913.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Percent of class represented by amount in row (9)

0.0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

LENZ Therapeutics, Inc.

(b)

Address of issuer's principal executive offices:

201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CALIFORNIA, 92075.

Item 2.

(a)

Name of person filing:

Squarepoint Ops LLC Squarepoint Capital LLP Squarepoint Operations Private Limited Squarepoint (DIFC) Limited Squarepoint Master Fund Limited Squarepoint Core Master Fund Limited

(b)

Address or principal business office or, if none, residence:

Squarepoint Ops LLC Squarepoint Master Fund Limited Squarepoint Core Master Fund Limited 250 W 55th Street 32nd Floor, New York, NY 10019 USA Squarepoint Capital LLP Citypoint, One Ropemaker Street, London, EC2Y 9AW UK Squarepoint Operations Private Limited 88 Market Street, CapitaSpring, Level 49, 048948 Singapore Squarepoint (DIFC) Limited Unit L29-07, Level 29, ICD Brookfield Place, Dubai International Financial Centre, Dubai, United Arab Emirates

(c)

Citizenship:

Squarepoint Ops LLC- USA Squarepoint Capital LLP- United Kingdom Squarepoint Operations Private Limited- Singapore Squarepoint (DIFC) Limited- United Arab Emirates Squarepoint Master Fund Limited- Cayman Islands Squarepoint Core Master Fund Limited- Cayman Islands

(d)

Title of class of securities:

Common Stock

(e)

CUSIP No.:

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

Squarepoint Ops LLC- 1,593,246 Squarepoint Capital LLP- 1,593,246 Squarepoint Operations Private Limited- 1,593,246 Squarepoint (DIFC) Limited- 1,593,246 Squarepoint Master Fund Limited- 1,590,333 Squarepoint Core Master Fund Limited- 2,913

(b)

Percent of class:

Squarepoint Ops LLC- 5.08% Squarepoint Capital LLP- 5.08% Squarepoint Operations Private Limited- 5.08% Squarepoint (DIFC) Limited- 5.08% Squarepoint Master Fund Limited- 5.07% Squarepoint Core Master Fund Limited- 0.01% %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

(ii) Shared power to vote or to direct the vote:

(iii) Sole power to dispose or to direct the disposition of:

(iv) Shared power to dispose or to direct the disposition of:

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Squarepoint Ops LLC

Signature:	/s/ John Weitzer
Name/Title:	Chief Compliance Officer
Date:	04/08/2026

Squarepoint Capital LLP

Signature:	/s/ John Weitzer
Name/Title:	Chief Compliance Officer
Date:	04/08/2026

Squarepoint Operations Private Limited

Signature:	/s/ John Weitzer
Name/Title:	Chief Compliance Officer
Date:	04/08/2026

Squarepoint (DIFC) Ltd

Signature:	/s/ John Weitzer
Name/Title:	Chief Compliance Officer
Date:	04/08/2026

Squarepoint Master Fund Limited

Signature:	/s/ John Weitzer
Name/Title:	Chief Compliance Officer
Date:	04/08/2026

Squarepoint Core Master Fund Limited

Signature:	/s/ John Weitzer
Name/Title:	Chief Compliance Officer
Date:	04/08/2026

Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Squarepoint Ops LLC

You May Also Be Interested In

Create E-mail Alert Related Categories

Related Entities

Sign up for StreetInsider Free!

Free News Feed